Replimune Group Inc (NASDAQ: REPL) kicked off on Tuesday, down -25.07% from the previous trading day, before settling in for the closing price of $10.01. Over the past 52 weeks, REPL has traded in a range of $4.92-$17.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 13.08%. With a float of $61.80 million, this company’s outstanding shares have now reached $77.01 million.
The extent of productivity of a business whose workforce counts for 331 workers is very important to gauge. In terms of profitability, gross margin is 65.59%, operating margin of -5963.83%, and the pretax margin is -5634.14%.
Replimune Group Inc (REPL) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Replimune Group Inc is 19.76%, while institutional ownership is 89.58%. The most recent insider transaction that took place on Dec 16 ’24, was worth 124,200. In this transaction Chief Executive Officer of this company sold 10,000 shares at a rate of $12.42, taking the stock ownership to the 202,014 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Chief Strategy Officer proposed sale 15,000 for $12.57, making the entire transaction worth $188,550.
Replimune Group Inc (REPL) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 13.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to -19.52% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Take a look at Replimune Group Inc’s (REPL) current performance indicators. Last quarter, stock had a quick ratio of 11.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.14, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.53 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
The latest stats from [Replimune Group Inc, REPL] show that its last 5-days average volume of 1.39 million was superior to 0.82 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 57.35%. Additionally, its Average True Range was 0.77.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 12.69%, which indicates a significant increase from 1.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 133.45% in the past 14 days, which was higher than the 78.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.98, while its 200-day Moving Average is $11.29. Now, the first resistance to watch is $9.15. This is followed by the second major resistance level at $10.80. The third major resistance level sits at $11.64. If the price goes on to break the first support level at $6.66, it is likely to go to the next support level at $5.82. The third support level lies at $4.17 if the price breaches the second support level.
Replimune Group Inc (NASDAQ: REPL) Key Stats
The company with the Market Capitalisation of 577.61 million has total of 77,015K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -215,790 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -66,340 K.
